We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




International Symposium Aims to Improve Lab Medicine

By HospiMedica staff writers
Posted on 13 Sep 2006
A clinical laboratory education and accreditation organization called COLA (Columbia, MD, USA) convened its first International Symposium (Baltimore, MD, USA) from July 30-August 1, 2006, to discuss the role of laboratory medicine in relation to public-health needs and crises. More...
The two-day symposium dealt with the future of quality in medical laboratory testing.

Participants in the symposium included public health leaders from the Centers for Disease Control and Prevention (CDC, Atlanta, Georgia, USA), the U.S. Department of Health and Human Services (Washington, DC, USA), the World Medical Association (Ferney-Voltaire, France), the World Health Organization (WHO, Geneva, Switzerland), and other government and industry leaders from countries around the world.

"We need to understand where we are in the world as a first step, and to find out some of the common threads--issues we all share--around the world,” said Doug Beigel, CEO of COLA. "My insight is that leaders will emerge from different parts of the world to bring about quality in laboratory medicine.”

The group acknowledged that medical laboratories are the critical front line in diagnosis and treatment of diseases. A few major underlying themes of the meeting were lab quality and standards, the need to focus on the healthcare system in its entirety as opposed to specific diseases, and specific needs of labs around the world. Some of the specific topics discussed were the relevance of laboratory standards and training needs to laboratory personnel and the region; the misplaced focus on programs and funding for diseases rather than for entire healthcare systems; the lack of patient-centered standards and systems; the need for integration of the entire healthcare system; and the increasing role of governments in ensuring laboratory quality and information.



Related Links:
COLA

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.